Synaptogenix Inc

About Synaptogenix Inc

Synaptogenix (NASDAQ:SNPX) is focused on developing cutting-edge therapeutics for neurodegenerative diseases like Alzheimer's. The company is leveraging its proprietary technology to enhance synaptic growth and repair, aiming to address the unmet needs in this critical area. One of their primary projects is the development of Bryostatin-1, which has shown promise in stimulating synaptic regeneration and cognitive function in preclinical trials. Synaptogenix's efforts are driven by a commitment to improve the lives of patients and families affected by debilitating neurological conditions. Their objectives include advancing clinical trials, securing regulatory approvals, and ultimately bringing novel treatments to the market.

What is Synaptogenix Inc known for?

Snapshot

2012

Year founded

Employees

Fort Lee, United States

Head office

Loading Map...

Operations

All Locations

United States

Products and/or services of Synaptogenix Inc

Regenerative Therapeutics: Developing innovative treatments for neurodegenerative diseases, focusing on enhancing synaptic connections and cognitive function through regenerative medicine and targeted therapies.
Neurotrophic Small Molecule Programs: Researching small molecules to promote neuronal growth and protect against neurodegeneration, aiming to bolster synaptic health and improve patient outcomes.
Phase 2 Clinical Trials: Conducting advanced clinical trials for key drug candidates to evaluate their efficacy and safety in treating Alzheimer's disease and other cognitive disorders.
Collaborative Research Initiatives: Partnering with academic and pharmaceutical organizations to advance scientific understanding and accelerate the development of cutting-edge neurological treatments.
Milestone Achievements: Celebrating research breakthroughs and clinical milestones that drive future growth and reinforce a commitment to addressing unmet medical needs in neurology.
Innovative Drug Delivery Systems: Exploring new methods to enhance the delivery and effectiveness of therapeutic compounds, ensuring optimal targeting and sustained release in the central nervous system.